NIH Weekly Funding Opportunities and Policy Notices

Notice to Extend the Expiration Date for PAR-14-209 " NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44)"
Monday, February 6, 2017 - 10:41am
Notice NOT-NS-17-016 from the NIH Guide for Grants and Contracts
Notice to Extend the Expiration Date for PAR-14-208 " NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials and Clinical Research (R44)"
Monday, February 6, 2017 - 10:32am
Notice NOT-NS-17-015 from the NIH Guide for Grants and Contracts
Extension of Expiration Date for PAR-14-288 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)"
Monday, February 6, 2017 - 10:21am
Notice NOT-NS-17-013 from the NIH Guide for Grants and Contracts
Impact of Washington, DC Area Federal Office Operating Status on NIH Grant Application Due Dates
Monday, February 6, 2017 - 9:23am
Notice NOT-OD-17-041 from the NIH Guide for Grants and Contracts
NHLBI Priorities for HIV Research and Funding
Monday, February 6, 2017 - 8:30am
Notice NOT-HL-17-486 from the NIH Guide for Grants and Contracts
Notice of Change of Key Dates for PAR-16-249 "Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01)"
Monday, February 6, 2017 - 8:27am
Notice NOT-CA-17-023 from the NIH Guide for Grants and Contracts
Pre-Solicitation Notice: Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccine Research and Development, NIAID-DAIDS-NIHAI2016072
Monday, February 6, 2017 - 8:22am
Notice NOT-AI-17-012 from the NIH Guide for Grants and Contracts
Notice of Change of Key Dates for PAR-16-248 "Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21)"
Monday, February 6, 2017 - 8:18am
Notice NOT-CA-17-026 from the NIH Guide for Grants and Contracts
Notice of NLM's Participation in PA-17-101 "Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement (Admin Supp)"
Monday, February 6, 2017 - 8:03am
Notice NOT-LM-17-004 from the NIH Guide for Grants and Contracts
Notice of Information Clarifying Department of Defense Terminology for RFA-AT-17-001 "NIH-DoD-VA Pain Management Collaboratory Pragmatic Clinical Trials Demonstration Projects" (UG3/UH3 )
Monday, February 6, 2017 - 12:30am
Notice NOT-AT-17-004 from the NIH Guide for Grants and Contracts
Extension of Expiration Date for PAR-14-289 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)"
Monday, February 6, 2017 - 12:29am
Notice NOT-NS-17-014 from the NIH Guide for Grants and Contracts
Extension of Expiration Date for PAR-14-287 "NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)"
Monday, February 6, 2017 - 12:17am
Notice NOT-NS-17-012 from the NIH Guide for Grants and Contracts
Notice of Extension of Expiration Date for PAR-14-286 "NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)"
Friday, February 3, 2017 - 9:52am
Notice NOT-NS-17-011 from the NIH Guide for Grants and Contracts
Advancing our Understanding of the Brain Epitranscriptomics (R01)
Friday, February 3, 2017 - 9:12am
Funding Opportunity PAR-17-153 from the NIH Guide for Grants and Contracts. The "epitranscriptome" refers to chemical modifications of RNA molecules. RNA modifications in the brain have been reported to regulate the fate and function of both coding and noncoding RNAs and are emerging as a critical element of cellular function. The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and/or the associated modification proteins that act on RNA (readers, writers, and erasers) and play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders.
Advancing Our Understanding of the Brain Epitranscriptome (R21)
Friday, February 3, 2017 - 9:12am
Funding Opportunity PAR-17-152 from the NIH Guide for Grants and Contracts. The "epitranscriptome" refers to chemical modifications of RNA molecules. RNA modifications in the brain have been reported to regulate the fate and function of both coding and noncoding RNAs and are emerging as a critical element of cellular function. The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and in the associated modification proteins that act on RNA (readers, writers, and erasers) that play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders.
NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)
Friday, February 3, 2017 - 8:37am
Funding Opportunity PAR-17-154 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens collected as part of a previous cooperative agreement award from NIDCR.
Notice of Withdrawal of NIGMS Support for Administrative Supplements to the SC1, SC2, and SC3 Activity Codes in PA-16-287 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)"
Friday, February 3, 2017 - 8:23am
Notice NOT-GM-17-001 from the NIH Guide for Grants and Contracts
Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U24)
Friday, February 3, 2017 - 8:15am
Funding Opportunity RFA-MH-18-100 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Institute of Mental Health (NIMH) seeks applications to develop, sustain, enhance, and enrich a centralized national biorepository for genetic studies of psychiatric disorders for facilitation and acceleration of the scientific understanding of the genetic risk architecture underlying mental disorders. This effort is expected to involve a functionally integrated, multi-disciplinary team that will provide for open sharing of biosamples and data resources through a single, centralized, national resource to advance basic and translational research in the genetics of mental disorders.
Funding Opportunity Issued for the All of Us Research Program Engagement Partners
Thursday, February 2, 2017 - 9:19am
Notice NOT-PM-17-002 from the NIH Guide for Grants and Contracts
Notice of NCI's Participation in PA-17-101 "Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement (Admin Supp)"
Thursday, February 2, 2017 - 8:38am
Notice NOT-CA-17-030 from the NIH Guide for Grants and Contracts

Pages